Major Endocrine and Targeted Therapy Advances In the Treatment of HR+/HER2- Breast Cancer
Vicente Valero, MD, FACP
Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials
Jan H. Beumer, PhD, PharmD, PhD, DABT
Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials
Jan H. Beumer, PhD, PharmD, PhD, DABT
